Chemistry:SB-216641

From HandWiki
Revision as of 15:22, 26 June 2023 by LinXED (talk | contribs) (change)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Chemical compound
SB-216641
SB-216,641 structure.png
Clinical data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
Chemical and physical data
FormulaC28H30N4O4
Molar mass486.572 g·mol−1
3D model (JSmol)
  (verify)

SB-216641 is a drug which is a selective antagonist for the serotonin receptor 5-HT1B, with around 25x selectivity over the closely related 5-HT1D receptor.[1] It is used in scientific research,[2][3][4] and has demonstrated anxiolytic effects in animal studies.[5][6]

References

  1. "SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors". Naunyn-Schmiedeberg's Archives of Pharmacology 356 (3): 312–20. September 1997. doi:10.1007/PL00005056. PMID 9303567. 
  2. "5-Hydroxytryptamine 1B receptors mediate presynaptic inhibition of monosynaptic IPSC in the rat dorsolateral septal nucleus". Neuroscience Research 48 (3): 229–38. March 2004. doi:10.1016/j.neures.2003.11.004. PMID 15154669. 
  3. "Involvement of 5-HT1B receptors within the ventral tegmental area in regulation of mesolimbic dopaminergic neuronal activity via GABA mechanisms: a study with dual-probe microdialysis". Brain Research 1021 (1): 82–91. September 2004. doi:10.1016/j.brainres.2004.06.053. PMID 15328035. 
  4. "Serotonergic modulation of GABAergic and glutamatergic synaptic transmission in mechanically isolated rat medial preoptic area neurons". Neuropsychopharmacology 33 (2): 340–52. January 2008. doi:10.1038/sj.npp.1301396. PMID 17392733. 
  5. "Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression". Behavioural Pharmacology 15 (8): 523–34. December 2004. doi:10.1097/00008877-200412000-00001. PMID 15577451. 
  6. "The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action". The Journal of Pharmacy and Pharmacology 57 (2): 253–7. February 2005. doi:10.1211/0022357055399. PMID 15720791.